Predição de malignidade de tumores ovarianos utilizando marcadores tumorais, índice de risco e ROMA

Predição de malignidade de tumores ovarianos utilizando marcadores tumorais, índice de risco e ROMA

INTRODUÇÃO: O câncer de ovário é o mais letal de todos os cânceres ginecológicos e requer ser tratado por ginecologistas especializados em centros terciários para se obter melhor prognóstico. Este trabalho tem como objetivo analisar e comparar quatro estratégias diferentes para predizer a benignidad...

Full description

Bibliographic Details
Main Author:	Anton, Cristina
Other Authors:	Carvalho, Jesus Paula
Format:	Others
Language:	pt
Published:	Biblioteca Digitais de Teses e Dissertações da USP 2011
Subjects:	Antígeno Ca-125 CA 125 antigen Curva ROC Epididymal secretory proteins Marcadores biológicos de tumor Medição de risco Neoplasias ovarianas Ovarian neoplasms Proteínas secretadas pelo epidídimo Risk assessment ROC curve Sensibilidade e especificidade Sensitivity and specificity Tumor markers biological
Online Access:	http://www.teses.usp.br/teses/disponiveis/5/5139/tde-07122011-121820/

Similar Items

Predição de malignidade de tumores ovarianos utilizando marcadores tumorais, índice de risco e ROMA
by: Cristina Anton
Published: (2011)

Rastreamento e diagnóstico das neoplasias de ovário: papel dos marcadores tumorais
by: Francisco José Candido dos Reis
Published: (2005-04-01)

A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses
by: Cristina Anton, et al.
Published: (2012-01-01)

Comparación de pruebas diagnósticas desde la curva ROC
by: PABLO MARTÍNEZ-CAMBLOR
Published: (2007-12-01)

Propuesta de un modelo logístico para la probabilidad de instalación de datáfonos en una empresa ubicada en Bogotá
by: Elkin Javier Cruz Hurtado, et al.
Published: (2020-06-01)

Tuberculose Pélvica Simulando Tumor Ovariano: a Case Report Pelvic Tuberculosis Simulating Ovarian Tumor
by: Marcelo Ivo Campagnolo, et al.
Published: (2000-09-01)

The relationship between serum levels of CA 125 and the degree of differentiation in ovarian neoplasms
by: Eduardo Cambruzzi, et al.
Published: (2014-02-01)

Clinical management of incidental findings on pelvic adnexal masses
by: Daniel Spadoto Dias, et al.
Published: (2015-10-01)

Preditores antropométricos de hipertensão arterial sistêmica em mulheres quilombolas
by: PADILHA, Bruna Merten
Published: (2015)

Comparación de pruebas diagnósticas desde la curva ROC Comparing Diagnostic Tests from ROC Curve
by: PABLO MARTÍNEZ-CAMBLOR
Published: (2007-01-01)

Circunferência da cintura como instrumento de triagem de fatores de risco para doenças cardiovasculares em escolares Waist circumference as screening instrument for cardiovascular disease risk factors in schoolchildren
by: Gabriel G. Bergmann, et al.
Published: (2010-10-01)

CA 125: History, Current Status, and Future Prospects
by: Robert C., Jr Bast, et al.
Published: (2020-12-01)

Evaluación del desempeño diagnóstico del Índice de Riesgo de Malignidad II en mujeres con diagnóstico de masa anexial en un hospital de tercer nivel
by: Roberto A. García-Manzano, et al.
Published: (2021-07-01)

Evaluation of CA-125 and soluble CD-23 in patients with pelvic endometriosis: a case-control study Avaliação do CA-125 e CD-23 solúvel em pacientes com endometriose pélvica: estudo de caso-controle
by: Ivana Maria de Luna Ramos, et al.
Published: (2012-02-01)

Correlation of Cytohistlogical Expression and Serum Level of Ca125 in Ovarian Neoplasm
by: Chhanda Das, et al.
Published: (2014-03-01)

Evaluación de una prueba Elisa IgG de avidez para toxoplasma para el diagnóstico en el embarazo y correlación con IgM E IgA en el laboratorio del Centro de Investigaciones Biomédicas de la Universidad del Quindío, 2008 Evaluating a Toxoplasma IgG avidity ELISA test for diagnostic purposes during pregnancy and correlating it with Toxoplasma IgM and IgA in the Biomedical Research Centre’s laboratory at the Universidad del Quindío, 2008
by: Elizabeth Torres Morales, et al.
Published: (2008-09-01)

Peritoneal tuberculosis: radiographic diagnosis
by: Carolina Ospina-Moreno, et al.
Published: (2014-12-01)

The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment
by: Tyvette S. Hilliard
Published: (2018-08-01)

Krukenberg tumor in pregnancy: A pathologist's point of view
by: G V Chaitra, et al.
Published: (2017-01-01)

Borderline Ovarian Malignancies : A Single Institute Retrospective Study.
by: Rajshekhar Kundargi, et al.
Published: (2013-01-01)

The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
by: Zheng Li-e, et al.
Published: (2016-01-01)

Correlation of CA-125 with different stages of endometriosis
by: Runa Laila, et al.
Published: (2018-03-01)

Mass lesions of ovary - Tumor markers can be misleading
by: Moothiringode Chitrabhanu Savithri
Published: (2014-11-01)

CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy
by: Yilin Tong, et al.
Published: (2021-01-01)

Punto de corte óptimo de la concentración de cotinina en saliva para discriminar entre fumadores y no fumadores en la población adulta de Barcelona Optimal cut-point of salivary cotinine concentration to discriminate smoking status in the adult population in Barcelona
by: Jose M. Martínez-Sánchez, et al.
Published: (2009-12-01)

Tuberculosis peritoneal en una paciente con ascitis y masa anexial: Reporte de caso Peritoneal tuberculosis in a patient with ascites and an anexal mass: A case report
by: Germán García, et al.
Published: (2006-03-01)

Glycans as a target in the detection of reproductive tract cancers
by: Janković Miroslava, et al.
Published: (2008-01-01)

The role of Wilm’s Tumor1 immunohistochemical marker in surface epithelial ovarian tumors
by: Muna I. AL Hafedh, et al.
Published: (2015-07-01)

Prognostic Value of Tumor Markers, NSE, CA125 and SCC, in Operable NSCLC Patients
by: Dangfan Yu, et al.
Published: (2013-05-01)

Meigs’ syndrome with elevated serum cancer antigen 125 levels in a case of ovarian sclerosing stromal tumor
by: Jia-Hung Liou, et al.
Published: (2011-06-01)

Evaluating Specivity, Sensitivity, Positive and Negative Predictive Values of CA125 for Diagnosing Ovarian Cancer
by: Elahe Fini, et al.
Published: (2021-08-01)

Role of Serum Tumor Markers in Prognosis of Operable Non-small Cell Lung Cancer Patients
by: LI Shaolei, et al.
Published: (2018-01-01)

Extra-ordinary High CA-125 and CA19-9 Serum Levels in an Ovarian Endometrioma: Case Report
by: Marzieh Agha Hosseini, et al.
Published: (2009-06-01)

Over Kanserli Hastalarda CA-125 ve Seruloplazmin Düzeyleri
by: Mangala HEGDE, et al.
Published: (2015-09-01)

Association between preeclampsia and cancer antigen 125 in women attending antenatal clinic in Usmanu, Danfodiyo University Teaching Hospital, Sokoto
by: Yetunde Bolatito Aremu-Kasumu, et al.
Published: (2020-01-01)

Ovarian fibroma: An unusual morphological presentation with elevated CA-125
by: Arya Anupama, et al.
Published: (2008-10-01)

Preoperative assessment of ovarian tumors using a modified multivariate index assay
by: Hero A. Abdurrahman, et al.
Published: (2018-05-01)

Intra-Abdominal Desmoplastic Small Round Cell Tumor with Elevated Serum CA 125: A Case Report
by: Sheau-Fang Yang, et al.
Published: (2003-10-01)

Human telomerase reverse transcriptase expression in ovarian tumors
by: Awadh Ali Makhashen Maraei, et al.
Published: (2012-01-01)

Serum CA125, HE4 and ROMA index in elderly patients with ovarian cancer
by: Yan-Jun Wang, et al.
Published: (2018-02-01)